Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,661 | 4 | 43.4% |
| Travel and Lodging | $10,644 | 3 | 43.3% |
| Consulting Fee | $2,981 | 2 | 12.1% |
| Food and Beverage | $273.12 | 2 | 1.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk AS | $24,462 | 10 | $0 (2024) |
| Medtronic, Inc. | $97.46 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $627.46 | 2 | Novo Nordisk AS ($530.00) |
| 2023 | $23,932 | 9 | Novo Nordisk AS ($23,932) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $97.46 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/23/2024 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $530.00 | General |
| 01/09/2023 | Novo Nordisk AS | Rybelsus (Drug) | — | In-kind items and services | $10,114.80 | Research |
| Study: NN9924-4437 • Category: Diabetes | ||||||
| 01/09/2023 | Novo Nordisk AS | Rybelsus (Drug) | — | In-kind items and services | $313.18 | Research |
| Study: NN9924-4437 • Category: Diabetes | ||||||
| 01/09/2023 | Novo Nordisk AS | Rybelsus (Drug) | — | In-kind items and services | $175.66 | Research |
| Study: NN9924-4437 • Category: Diabetes | ||||||
| 01/09/2023 | Novo Nordisk AS | Rybelsus (Drug) | — | In-kind items and services | $57.54 | Research |
| Study: NN9924-4437 • Category: Diabetes | ||||||
| 01/02/2023 | Novo Nordisk AS | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $10,114.80 | General |
| Category: Diabetes | ||||||
| 01/02/2023 | Novo Nordisk AS | Rybelsus (Drug) | Consulting Fee | Cash or cash equivalent | $2,451.25 | General |
| Category: Diabetes | ||||||
| 01/02/2023 | Novo Nordisk AS | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $313.18 | General |
| Category: Diabetes | ||||||
| 01/02/2023 | Novo Nordisk AS | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $215.73 | General |
| Category: Diabetes | ||||||
| 01/02/2023 | Novo Nordisk AS | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $175.66 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN9924-4437 | Novo Nordisk AS | $10,661 | 4 |
About Nancy Chang, NP
Nancy Chang, NP is a Pediatric Endocrinology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2019. The National Provider Identifier (NPI) number assigned to this provider is 1447819388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nancy Chang, NP has received a total of $24,559 in payments from pharmaceutical and medical device companies, with $627.46 received in 2024. These payments were reported across 11 transactions from 2 companies. The most common payment nature is "" ($10,661).
Practice Information
- Specialty Pediatric Endocrinology
- Location Los Angeles, CA
- Active Since 06/12/2019
- Last Updated 06/12/2019
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1447819388
Products in Payments
- Rybelsus (Drug) $23,932
- INTELLIS ADAPTIVESTIM (Device) $97.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Los Angeles
Mitchell Geffner, Md, MD
Pediatric Endocrinology — Payments: $223,773
Francine Kaufman, M.d, M.D
Pediatric Endocrinology — Payments: $178,659
Roshanak Monzavi, Md, MD
Pediatric Endocrinology — Payments: $19,121
Dr. Alaina Vidmar, M.d, M.D
Pediatric Endocrinology — Payments: $17,889
Lynda Fisher, Md, MD
Pediatric Endocrinology — Payments: $13,941
Dr. David Geller, M.d, M.D
Pediatric Endocrinology — Payments: $6,985